BR112012016744A2 - "método e kits para detectar fatores de risco para o desenvolvimento de osteonecrose da mandíbula e métodos de tratamento da mesma" - Google Patents

"método e kits para detectar fatores de risco para o desenvolvimento de osteonecrose da mandíbula e métodos de tratamento da mesma"

Info

Publication number
BR112012016744A2
BR112012016744A2 BR112012016744A BR112012016744A BR112012016744A2 BR 112012016744 A2 BR112012016744 A2 BR 112012016744A2 BR 112012016744 A BR112012016744 A BR 112012016744A BR 112012016744 A BR112012016744 A BR 112012016744A BR 112012016744 A2 BR112012016744 A2 BR 112012016744A2
Authority
BR
Brazil
Prior art keywords
kits
treating
development
methods
risk factors
Prior art date
Application number
BR112012016744A
Other languages
English (en)
Portuguese (pt)
Inventor
Katz Joseph
Original Assignee
Univ Of Fl Orida Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Fl Orida Res Found Inc filed Critical Univ Of Fl Orida Res Found Inc
Publication of BR112012016744A2 publication Critical patent/BR112012016744A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112012016744A 2010-01-06 2010-12-13 "método e kits para detectar fatores de risco para o desenvolvimento de osteonecrose da mandíbula e métodos de tratamento da mesma" BR112012016744A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29273010P 2010-01-06 2010-01-06
PCT/US2010/060139 WO2011084387A2 (en) 2010-01-06 2010-12-13 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof

Publications (1)

Publication Number Publication Date
BR112012016744A2 true BR112012016744A2 (pt) 2017-06-13

Family

ID=44306025

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012016744A BR112012016744A2 (pt) 2010-01-06 2010-12-13 "método e kits para detectar fatores de risco para o desenvolvimento de osteonecrose da mandíbula e métodos de tratamento da mesma"

Country Status (9)

Country Link
US (1) US20130035314A1 (https=)
EP (1) EP2521793A4 (https=)
CN (1) CN102812132A (https=)
AU (1) AU2010340161A1 (https=)
BR (1) BR112012016744A2 (https=)
CA (1) CA2786545A1 (https=)
IN (1) IN2012DN06571A (https=)
RU (1) RU2012133434A (https=)
WO (1) WO2011084387A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010005939A1 (en) * 2008-07-07 2010-01-14 University Of Florida Research Foundation, Inc. Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof
WO2015083163A1 (en) * 2013-12-04 2015-06-11 Micromedic Technologies Ltd. Methods and kits for identifying susceptability to antiresorptive-agent-induced osteonecrosis of the jaw
CN111518882B (zh) * 2019-02-03 2022-06-28 陈卫衡 通过分子标志物辨识激素性股骨头坏死的中医证型的系统
CN112410413A (zh) * 2020-09-24 2021-02-26 吉林大学 Onfh易感相关vdr、mmp2、mmp3、mmp9基因snp的检测物质及应用
ES2994026A1 (es) * 2023-07-11 2025-01-16 Fundacion Instituto De Investig Sanitaria De Santiago De Compostela Metodo in vitro para identificar si un sujeto tratado con agentes modificadores de los huesos puede desarrollar osteonecrosis de los maxilares

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062465A1 (es) * 2002-01-25 2003-07-31 Universidad De Barcelona Compuestos para el diagnóstico de la predisposición a la osteoporosis
WO2010005939A1 (en) * 2008-07-07 2010-01-14 University Of Florida Research Foundation, Inc. Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof

Also Published As

Publication number Publication date
CA2786545A1 (en) 2011-07-14
RU2012133434A (ru) 2014-02-27
EP2521793A4 (en) 2013-07-03
AU2010340161A1 (en) 2012-07-26
US20130035314A1 (en) 2013-02-07
IN2012DN06571A (https=) 2015-10-23
EP2521793A2 (en) 2012-11-14
WO2011084387A2 (en) 2011-07-14
WO2011084387A3 (en) 2011-10-27
CN102812132A (zh) 2012-12-05

Similar Documents

Publication Publication Date Title
EA201270676A1 (ru) Полиморфная, кристаллическая и мезофазная формы 2-(5-бром-4-(4-циклопропилнафталинил-1-ил)-4н-1,2,4-триазол-3- илтио)ацетата натрия и их применение
BR112013016982A2 (pt) formas polimórficas de ácido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acético e usos destes
CL2019003049A1 (es) Compuestos de heteroarilo bicíclicos 6-6 fusionados y su uso como inhibidores de lats.
EA201390772A1 (ru) Новые соли и полиморфные формы афатиниба
CY1120318T1 (el) Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων
BR112016015236A8 (pt) composto,composição farmacêutica,uso de um composto,método de inibição e método para tratar ou aliviar a gravidade de uma doença.
CY1120031T1 (el) Αποπτωτικοι υποκινητες ν-ακυλοσουλφοναμιδης
MD4820B1 (ro) Compuşi dihidroizochinolinonici substituiţi
BR112017012342A2 (pt) compostos inibitórios de bcl-xl e conjugados de anticorpo-fármaco incluindo os mesmos
CY1118319T1 (el) Αλατα και πολυμορφα της 8-φθορο-2-{4-[(μεθυλαμινο)μεθυλο]φαινυλο}-1,3,4,5-τετραϋδρο-6η-αζεπινο[5,4,3-cd]ινδολο-6-ονης
CY1118129T1 (el) 5-αλκυνυλ-πυριμιδινες
MX2020002924A (es) Lactamas fusionadas de arilo y heteroarilo.
EA201200174A1 (ru) Производные оксазина и их применение в качестве ингибиторов bace для лечения неврологических нарушений
BR112015001608A2 (pt) inibidor lfa-1 e polimorfo do mesmo
CY1117105T1 (el) Ενωσεις πυριδαζινονης και χρηση τους ως αναστολεις του daao
DK2321295T3 (da) 4-(pyridin-4-yl)-1h-[1,3,5]triazin-2-olderivater som gsk3-beta inhibitorer for til behandling af neurodegenerative sygdomme
IT1391866B1 (it) Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari.
PH12014501991A1 (en) Phenicol antibacterials
BR112017026535A2 (pt) composto de fórmula estrutural i, enantiômero isolado, composição farmacêutica, método para inibir atividade do transportador de monocarboxilato mct4, método para inibir seletivamente atividade do transportador de monocarboxilato mct4, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 e uso de um composto
BR112012016744A2 (pt) "método e kits para detectar fatores de risco para o desenvolvimento de osteonecrose da mandíbula e métodos de tratamento da mesma"
CY1120133T1 (el) Πυριδαζινονες ως αναστολεις ενζυμου daao
CL2013002971A1 (es) Compuestos derivados de 5-(fenil/piridinil-etinil)-2-piridina/2-pirimidina-carboxamida, moduladores mglur5; composición farmacéutica que los comprende; proceso de preparación de ellos; y su uso en el tratamiento de esquizofrenia o enfermedades cognitivas.
CY1121060T1 (el) Παραγωγα [1,2,4] τριαζολο[1,5-α] πυριμιδινης ως αναστολεις πρωτεασωματος πρωτοζωων για τη θεραπεια παρασιτικων νοσηματων οπως η λεϊσμανιαση
WO2012107890A3 (en) Crystal forms of lurasidone chlorhydrate
CL2015001187A1 (es) Compuestos derivados de azaquinolin-carboxamida, como inhibidores de p70s6k; su metodo de manufactura; composicion farmaceutica que los comprende; y su uso para el tratamiento profilactico o terapeutico de trastornos hiperproliferativos, cancer, retinopatia diabetica, dolor, eczema y degeneracion macular relacionada con la edad, entre otras enfermedades.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]